Company / CapEx per Share
Immunome Inc. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.15
FY2025
5-year range
$0.01 / $0.15
FY2021-FY2025
Trend
+682.0%
vs FY2024
Sector context
#48 of 192
Health Care
What the data says
CapEx per Share changed +682% YoY in FY2025, a notable deviation from the 6-year average annual change of +127%.
Based on SEC 10-K filings.
0.15 in FY2025 with a 5-year CAGR of -2.8%. Top quartile in the Health Care sector.
Improved from $0.02 to $0.15 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +94.4%
- 5-Year CAGR
- -2.8%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 192This company $0.15 Sector average $2.46
▼
-93.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 682.0% year-over-year.
- Ranks #48 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.15 | +682.0% |
| FY2024 | $0.02 | -6.0% |
| FY2023 | $0.02 | -0.0% |
| FY2022 | $0.02 | +198.7% |
| FY2021 | $0.01 | -96.0% |
| FY2020 | $0.17 | -18.8% |
| FY2019 | $0.21 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026